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Abstract: External ventricular drains and lumbar drains are
commonly used to divert cerebrospinal fluid and to measure
cerebrospinal fluid pressure. Although commonly encountered
in the perioperative setting and critical for the care of neuro-
surgical patients, there are no guidelines regarding their man-
agement in the perioperative period. To address this gap in the
literature, The Society for Neuroscience in Anesthesiology &
Critical Care tasked an expert group to generate evidence-based
guidelines. The document generated targets clinicians involved
in perioperative care of patients with indwelling external ven-
tricular and lumbar drains.
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External ventricular drains (EVDs) and lumbar drains(LDs) are temporary devices placed into the lateral
ventricles of the brain and lumbar subarachnoid space,
respectively, to facilitate external cerebrospinal fluid
(CSF) drainage and to monitor CSF pressure. Their
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placement is considered one of the most frequently per-
formed procedures in neurologically critically ill pa-
tients,1–3 with the majority placed in patients with
subarachnoid hemorrhage (SAH), intracerebral hemor-
rhage, and obstructive hydrocephalus.4 Although the
worldwide incidence of placement of EVD and LD is
largely unknown, it is estimated that 500,000 ven-
triculostomies were placed in the United States alone
between 1988 and 2010.4 Since its first placement in 1744,
EVDs have undergone numerous changes in materials,
techniques, and indications.5–7
EVDs are commonly encountered in perioperative
care by clinicians, specifically the anesthesia providers
who might have limited experience in their management.
Furthermore, mismanagement of EVDs can have cata-
strophic consequences. Despite their importance, there
are currently no guidelines for the perioperative man-
agement of EVD and LD.
METHODOLOGY
Purpose of the Guidelines
These evidence-based guidelines aim to provide
recommendations related to EVD and LD regarding (1)
common indications, contraindications, complications,
and patient preparation for placement and maintenance;
(2) preoperative assessment of patients; (3) transporting
patients; (4) intraoperative management including mon-
itoring and CSF drainage; (5) management of these drains
under special circumstances; and (6) creating a perioper-
ative checklist, clinical competency, and continued med-
ical education.
Application
These guidelines are intended for the use by clini-
cians involved in perioperative care of adult patients with
EVDs and LDs.
Task Force Members
The initial concept and design of “Society for
Neuroscience in Anesthesiology & Critical Care
(SNACC) EVD/LD project” began in November 2015,
and an EVD/LD task force was finalized in December
2015. This task force comprised of 10 neuro-
anesthesiologists and neurointensivists practicing at aca-
demic medical centers across the United States and
Canada. These 10 individuals were chosen after an e-mail
invitation was sent to all active SNACC members seeking
project membership. Applicants were required to have
published peer-reviewed neuroscience research or have
documented experience in the care of patients with EVD
and LD. The task force members agreed on criteria for
evidence and then evaluated peer-reviewed studies per-
taining to EVD and LD (search strategies described in
next section). The document was compiled of 6 sections,
with each section equally coauthored by 2 project mem-
bers, and was subsequently reviewed and approved by
all members of the task force. The completed draft
was submitted to the SNACC Board of Directors. After
incorporating the inputs and suggestions from the
SNACC Board of Directors, the approved version was
placed on the SNACC Web site (http://www.snacc.org)
for member review and comments for a period of 1
month, with the final version of the guideline confirmed
after incorporating member input.
AVAILABILITY AND STRENGTH OF EVIDENCE
The task force worked with a medical librarian to
create a systematic strategy to search PubMed: (external
ventricular drain*[tw] OR external ventricle drain*[tw]
OR extraventricular drain*[tw] OR extra ventricular
drain*[tw] OR ventricular catheter*[tw] OR ventricular
access device*[tw] OR lumbar drain*[tw] OR cere-
brospinal fluid drain*[tw] OR csf drain*[tw]) OR (ven-
triculostom*[tw] AND (drain*[tw] OR catheter*[tw])).
The format of this search was adapted for Embase
through Elsevier. Search results were limited to journal
articles and conference papers published in English and
last updated on December 26, 2016. The total search re-
sults (7936 references) were downloaded to Endnote.
After 2729 duplicates were removed, 5207 articles were
imported to a Covidence database for team review. Au-
thors had previously identified 119 additional articles,
and 91 articles were found by the authors including
checks of reference lists as the review progressed.
Several rounds of screening were conducted, with
review of each of the titles and abstracts from the original
search by 2 reviewers. Inclusion criteria were all study
types in adults, and exclusion criteria were nonhuman
studies, laboratory investigations, and pediatric literature.
References addressing infectious complications and pre-
vention strategies published before the 2015 Neurocritical
Care Society (NCS) guidelines8 and those addressing CSF
drainage for spinal cord protection published before the
2010 ACC guidelines9 were eliminated. Ultimately a pool
of 646 references were identified and organized by topic
for the individual section authors to draw upon in con-
struction of the guidelines.
We used the American Heart Association methodo-
logy for the level of evidence for each recommendations
proposed10 (Table 1).
SECTION 1: INTRODUCTION TO EVDs AND LDs
Common Indications for Placement of EVDs
and LDs
EVDs function as intracranial pressure (ICP)
monitors and as conduits for external CSF diversion.
LDs, in contrast, function primarily as a conduit for ex-
ternal CSF drainage, and are not used for ICP monitor-
ing. Although both parenchymal ICP monitors and
EVDs provide reliable and accurate ICP data, EVDs are
preferred in patients with hydrocephalus.11
Major indications for placement of EVD and LD
are presented in Table 2.
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Placement of EVDs and LDs
EVDs are frequently inserted emergently at bedside
rather than in the operating room (OR).47,48 The frontal
horn of the right lateral ventricle is the preferred destination
as this is assumed to be in the nondominant side for speech
and language in most patients.47,49 Although different
techniques for EVD placement have been described in the
literature,3,50–52 anatomic landmarks are frequently used
and the drain is placed free handed.49,51,53–57
LDs are placed in a manner similar to a lumbar
puncture, epidural, or intrathecal catheter placement.58
Placement of an LD may be done preoperatively in an
awake patient, or after the induction of anesthesia. Co-
agulation profile and anticoagulation medications should
be reviewed and anticoagulants held per current Ameri-
can Society of Regional Anesthesia and Pain Medicine
(ASRA) guidelines (refer to Supplement 1, Supplemental
Digital Content 1, http://links.lww.com/JNA/A46). The
patient is placed in the lateral decubitus or sitting posi-
tion. Using strict aseptic technique, the lumbar catheter is
typically inserted at the L3-L4 or L4-L5 level through a
14-G Tuohy needle. A special, kink-resistant, flexible
catheter is passed through the Tuohy needle into the in-
trathecal space.58 The catheter with the guidewire is
threaded approximately 5 to 8 cm past the needle into the
intrathecal space and secured with a clear dressing. It
should be stressed that the catheter should thread easily,
like an epidural catheter. If resistance is felt, or the
catheter is unable to be placed, both the needle and
catheter should be removed as a single unit to prevent
inadvertent shearing of the catheter. The catheter should
be flushed with 10mL sterile saline flush and connected to
a sterile pressure monitoring kit and a closed collection
system. The transducer should not be connected to any
pressured flushing system. When connecting the trans-
ducer to a collection system ensure a continuous fluid
column. This can be achieved by allowing CSF to drain
back to the stopcock at the transducer. Bloody CSF or
aspiration of blood during placement requires avoidance
of anticoagulation for 24 hours.
Optimizing Patients Before Placement of EVDs
or LDs
Contraindications to placement of EVD or LD in-
clude coagulopathy and infection at the entry site. LD
also needs careful screening to rule out non-
communicating hydrocephalus and large intracranial
mass lesions.24 The ASRA guidelines on anticoagulation
should be consulted to determine appropriateness of
placement and removal of the LD.59 It is generally ad-
vised to diagnose and promptly correct coagulopathies
before placement of either monitor.8,60
TABLE 1. Summary of Class (Strength) of Recommendation
and Level (Quality) of Evidence
Class (strength) of recommendation
Class I (strong) benefit> > >risk
Class IIa (moderate) benefit> >risk
Class IIb (weak) benefitZrisk
Class III: no benefit (benefit=risk)
Class III: harm (strong) risk>benefit
Level (quality of evidence)
Level A High-quality evidence from >1 RCTs
Meta-analyses of high-quality RCTs
Z1 RCTs corroborated by high-quality registry
studies
Level B:
randomized
Moderate-quality evidence from Z1 RCTs
Meta-analyses of moderate-quality RCTs
Level B:
nonrandom-
ized
Moderate-quality evidence from Z1 well-designed,
well-executed nonrandomized studies,
observational studies, or registry studies
Meta-analyses of such studies
Level C Randomized or nonrandomized observational or
registry
Studies with limitations of design or execution
Meta-analyses of such studies
Physiological or mechanistic studies in human
subjects
Level E Consensus of expert opinion based on clinical
experience when evidence is insufficient, vague, or
conflicting
RCT indicates randomized controlled trial.
TABLE 2. Major Indications for Placement of External
Ventricular and Lumbar Drains
External ventricular drains
Acute symptomatic hydrocephalus
Aneurysmal SAH12–14
ICH and IVH with decreased level of consciousness15
Acute ischemic cerebellar stroke in concurrence with decompressive
craniectomy16,17
ICP monitoring in TBI
TBI with postresuscitation GCS of 3-8, and abnormal CT scan
defined as one with hematomas, contusions, swelling, herniation, or
compressed basal cisterns18–20
Severe TBI with a normal CT scan if Z2 of the following features
are noted on admission (age over 40 y, unilateral or bilateral motor
posturing, or SBP<90mm Hg18,19
Management of patients with intracranial hypertension after
TBI21,22
Malfunctioning or infected ventriculoperitoneal shunts, and other
neurological emergencies occurring due to infective and neoplastic
diseases23–26
Facilitation of intraoperative brain relaxation27,28
Targeted therapeutic interventions
rTPA in patients with IVH29,30 (efficacy and safety uncertain) and in
patients with SAH31,32
Treatment of vasospasm after aneurysmal SAH33–35
Antibiotics in management of central nervous system infections36,37
Lumbar drains
Acute symptomatic hydrocephalus in SAH12
Spinal cord–protective strategy in open and endovascular thoracic
aortic repair for patients at high risk of spinal cord injury9,24,38–40
Active CSF leak (due to craniofacial trauma)41 or those at risk for
CSF leak during skull base procedures42–44; however, lumbar drains
do not prevent postoperative CSF leaks44,45
Facilitate intraoperative brain relaxation27 and intraoperative
exposure46
CSF indicates cerebrospinal fluid; CT, computed tomography; GCS, Glasgow
Coma Score; ICH, intracerebral hemorrhage; IVH, intraventricular hemorrhage;
rTPA, recombinant tissue plasminogen activator; SAH, subarachnoid hemor-
rhage; SBP, systolic blood pressure; TBI, traumatic brain injury.
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Complications Associated With EVDs and LDs
Complications associated with EVD placement
are common61 requiring revision in 10% to 22% of
cases.47,62 Table 3 highlights complications associated
with EVDs and LDs. Although hemorrhage, infections,
and overdrainage of CSF are the most recognized com-
plications, clinicians involved in perioperative care must
be familiar with other possible complications.
Hemorrhagic Complications Associated With EVD
and LD
There are 2 main risk factors for hemorrhagic
complications: (1) coagulopathy and (2) overdrainage of
CSF. Factors such as cerebrovascular disease, size of
catheter,107 use of antiplatelet agents,108 and INR>
1.6,109 place patients at risk for ventriculostomy-
associated hemorrhage. Although most of these bleeds
are clinically insignificant,2,110,111 they can be potentially
devastating.8,66 Removal of EVD also poses risk for
hemorrhage. In a retrospective study of 482 EVDs by
Miller and Tummala,66 hemorrhage was seen in 22.5% of
those patients who underwent post-EVD neuroimaging.
Factors associated with hemorrhage included bedside
placement of EVD. Interestingly, the investigators were
unable to demonstrate impact of INR value, platelet
count, and antiplatelet agents on incidence of hemor-
rhage. Proposed mechanisms of hemorrhage associated
with removal of EVD include: injury to and release of any
tamponade effect on a small vessel, tracking of scalp
bleeding along EVD track, and possible adherence of
EVD to choroid plexus that may contribute to bleeding
on removal. Majority of the hemorrhages in this series
were small and asymptomatic.66
Hemorrhagic Complications Associated With Chem-
ical Prophylaxis Against Venous Thromboembolism.
Contrary to popular concern, chemical prophylaxis
against venous thromboembolism started within 24 hours
of admission and therapeutic heparinization initiated
within 24 hours of placement of the EVD does not in-
crease bleeding risk.112,113 The incidence of hemorrhage
during removal of EVD can be higher than during
placement,66 and similar indices of coagulopathy must be
maintained before removal of EVD.
Placement of LD in Patients Requiring Systemic
Anticoagulation. Placing a LD in an anesthetized patient
is safe, even in patients requiring subsequent heparin-
ization and cardiopulmonary bypass.74,114 The risk of
hematoma and neurological injury is rare, and can be
minimized by following certain guidelines, that is, delay-
ing surgery 24 hours in the event of a traumatic tap
(blood freely aspirated), delaying heparinization for
>60 minutes after catheter insertion, and maintaining
tight perioperative control of anticoagulation.115 Neu-
raxial hematoma associated with placement or removal of
a LD is a rare but potentially serious complication. The
reported incidence of surgical decompression required
after epidural catheterization varied between 1/22,189
and 1/4330 in a cohort of 62,450 nonaortic surgery pa-
tients.116 Of note, 4 of the 7 patients who developed a
neuraxial hematoma had perioperative anticoagulation
management deviated from current ASRA guide-
lines.116,117
There are limited data on the incidence of neuraxial
hematoma associated with LDs during aortic surgery re-
quiring systemic anticoagulation, but has been reported
as between 0% and 4%.67,72,73
A summary of the ASRA guidelines pertinent to
LDs117 and NCS consensus statement8 on management of
EVD can be found in the supplement document attached
to the guidelines (refer to Supplement 1, Supplemental
Digital Content 1, http://links.lww.com/JNA/A46).
Infectious Complications
Infections associated with EVD (0% to 28%) and
LD (0% to 50%) are among the most serious of com-
plications.8,69–75 Factors associated with increased in-
fection risk include nontunneled catheters, nonsterile
conditions, intraventricular hemorrhage, frequent sam-
pling, irrigation of catheters, and longer in situ dura-
tion.70,118 Adherence to an aseptic technique, that is,
cleaning the insertion site using an antimicrobial agent
per local antibiogram, and using a dressing as a part of a
management bundle, institution of pre-EVD-insertion
antibiotics, using antimicrobial-impregnated catheters
whenever possible,8,62,119–125 avoiding routine CSF sam-
pling, and limited manipulation of the CSF collecting
system, all feature in the recommendations provided in
the recently published NCS consensus statement on EVD
insertion and management.8 To limit potential for Clos-
tridium difficile diarrhea and antimicrobial-resistant or-
ganisms, as well as lack of efficacy, antibiotics are not
routinely recommended for the duration of the EVD.8
Although there are no guidelines or consensus
statements regarding intraoperative periprocedural
TABLE 3. Complications Associated With EVD and LD
Hemorrhage
Intracerebral hemorrhage, tract hematoma, or tract hemorrhages
(0%-41%)1,8,63–66
Neuraxial hematoma (0%-3.2%)67
Neural injury68
Infection (0%-28% EVD, 0%-50% LD)8,69–75
Malposition2,76
Occlusion and malfunction77–79
Overdrainage of CSF
Subdural or epidural hematoma80–83
Rebleeding from a ruptured cerebral aneurysm84
Intracranial hypotension85–87
Cerebellar tonsillar herniation79,88–91
Paradoxical herniation92
Pneumocephalus79,93
Iatrogenic vascular injury (arteriovenous fistula, cerebral
pseudoaneurysm)94
Fracture of catheters,95 with retained fragment of catheter96,97
Inadvertent injections of drugs into EVDs98–105
Postdural puncture headache106
CSF indicates cerebrospinal fluid; EVD, external ventricular drain; LD,
lumbar drain.
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administration of antibiotics before LD placement for
aortic and nonaortic surgery, this task force recommends
following standards such as those used for EVD insertion
and management.
Summary
Although there are many indications for the place-
ment of EVD or LD, they are critical to monitor intra-
cerebral or intraspinal pressure (ISP). Thorough
knowledge of indications, contraindications, complica-
tions, and cautions associated with the monitoring mo-
dality, along with strict adherence to local, national, and
international standards will likely enhance patient safety.
Prevention of Hemorrhagic and Infectious Com-
plications Associated with EVDs and LDs (Class of
Recommendation and Level of Evidence):
(1) Before insertion of EVD and LD, prompt diagnosis
and correction of coagulopathy utilizing institutional
practice guidelines is recommended (Class I Recom-
mendation; Level of Evidence E).
(2) Perioperative anticoagulation management with LD
placement and removal during aortic or nonaortic
surgery should be performed within the framework of
the current ASRA guidelines (Class I Recommenda-
tion; Level of Evidence E).
(3) Antibiotics should only be administered before place-
ment of an EVD and LD with the choice based on
institutional practice (Class I Recommendation; Level
of Evidence E).
(4) It is recommended to practice strict aseptic technique
based on national and institutional guidelines (Class I
Recommendation; Level of Evidence E).
SECTION 2: PREOPERATIVE EVALUATION OF
PATIENT WITH EVD AND LD
Background
A thorough preanesthetic evaluation of patients
with EVD and LD is critical for optimal perioperative
care. Table 4 describes components of history, physical
examination, laboratory, and imaging data that should be
incorporated into the preanesthetic assessment.
Parts of evaluation that are unique to EVDs include
reviewing indication for placement, relevant history,
medications given, ICP trends, qualitative evaluation of
components of ICP waveforms, and any data available
from EVD clamp trials. P1:P2 waveform evaluation
would be significant to understand ICP compliance curve,
and EVD clamp trial data would be significant to un-
derstand impact of EVD clamping on ICP during patient
transport.
Inspection of the EVD or LD System
Inspection of EVD and LD system must be per-
formed to provide information regarding (1) integrity of
the system, (2) color and consistency of CSF, and (3)
leveling and zeroing of the transducer system.
Baseline color and consistency of CSF, as well as
presence of air bubbles or debris should be noted in the
catheter and the burette (rather than the collecting bag),
and sudden change in color of CSF at any given time
deserves attention (see Section 5 for further details).
EVDs are leveled at the external auditory meatus
using either a Carpenter bubble or a laser level. LDs, in
contrast, are leveled at the right atrium (phlebostatic axis)
or at the lumbar catheter insertion site.
Understanding “Drain Dynamics” or “Setting of
EVD and LD”
CSF drainage through EVD and LD is performed
under controlled conditions to prevent overdrainage.
Establishing CSF drain volume goals is an important part
of this with a goal of 10 to 20mL/h as this is the typical
hourly CSF production and volume that resides in the
ventricular system.126 To avoid overdrainage, bridging
vein tear, and ultimately subdural bleed, drainage of
EVD/LD >15 to 20mL in any hour should accompany
consultation of a neurosurgeon. The bedside notes should
clearly indicate whether the goals are hourly drainage of
TABLE 4. Preoperative Assessment of Patients With External
Ventricular and Lumbar Drain
History Comments
Diagnosis SAH, ICH, IVH, AIS, TBI, skull base surgery,
CSF leak
Medications Anticoagulant drugs, antiplatelet drugs
Liver or renal disease Associated with coagulopathy
Cancer or
hematological
disorders
Associated with coagulopathy
Physical examination
Vital signs SpO2, PO2, EtCO2, PCO2, MAP, CPP
ICP data ICP range, ICP waveform, P1:P2 ratio
EVD clamp trial results
CSF data Hourly CSF output, output over 24 h
Color of CSF (clear, xanthochromia, bloody,
etc.)
Multimodal
monitoring data
PbtO2, microdialysis, and autoregulation
studies
Focused neurological
examination
GCS, FOUR score, cranial nerve paresis,
brainstem reflexes, presence or absence of
focal neurodeficits
Inspection of EVD or
LD system
Tunneled catheter system
Setting of EVD with reference to zero
Leveling of EVD at EAM
Leveling of LD at phlebostatic axis/EAM
Laboratory data
Complete blood
count
Correct thrombocytopenia
PT, INR, PTT Prompt reversal of coagulopathy
Imaging data
CT or MRI findings Site and location of EVD
Midline shift, cerebral edema
AIS indicates acute ischemic stroke; CPP, cerebral perfusion pressure; CSF,
cerebrospinal fluid; CT, computed tomography; EAM, external auditory meatus;
EtCO2, end-tidal carbon dioxide; FOUR, Full Outline of Responsiveness Score;
GCS, Glasgow Coma Score; ICH, intracerebral hemorrhage; ICP, intracranial
pressure; INR, international normalized ratio; IVH, intraventricular hemorrhage;
MAP, mean arterial pressure; MRI, magnetic resonance imaging; Pbto2, brain
tissue oxygenation; PCO2, partial pressure of carbon dioxide; PO2, partial pressure
of oxygen; PT, prothrombin time; PTT, partial thromboplastin time; SAH, sub-
arachnoid hemorrhage; SpO2, pulse oximetry; TBI, traumatic brain injury.
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certain predetermined CSF volume or whether ICP data
can drive the drainage volume.
Setting of EVD depends upon indication for placing
catheters. In patients with aneurysmal SAH, EVDs are
typically set at +20 cm H2O, before clipping or coiling of
ruptured cerebral aneurysm, and EVD setting is lowered
to +10 cm H2O after aneurysm repair has been com-
pleted. Although these are arbitrary numbers, clinicians
involved in perioperative care must familiarize themselves
to their respective institutional practices. Sudden over-
drainage of CSF in a patient with unsecured ruptured
cerebral aneurysm predisposes to rebleeding due to sud-
den widening of transmural pressure gradient (MAP-ICP)
across the aneurysm wall.84 A recent survey of US-based
neurointensivists and neurosurgeons revealed that most
institutions utilize a strategy involving continuously open
EVD to enhance CSF drainage in a patient with secured
cerebral aneurysm along with a gradual weaning strat-
egy.127
In patients with ICH, EVDs are set to provide
drainage so that an intraventricular clot does not develop
by stasis, and thus avoids blocking ventricular system
passages and egresses that lead to noncommunicating
hydrocephalus and impending herniation.128
Results of Clamping Trials
EVDs and LDs are routinely clamped during
change in patient positioning, such as occurring during
turning patients in the intensive care unit (ICU) and
getting patients out of bed to chair or during ambulation,
and remains the recommended standard of practice.129
Tolerance of patients to any period of clamping
depends upon the primary reason for placement of EVD
or LD, ICP trends, and dependency on external CSF di-
version. Patients at risk for clamp failure include those
dependent on external CSF diversion, such as occurring
with acute hydrocephalus, and in situations of elevated
ICP.8
The preoperative evaluation of all patients with an
indwelling EVD/LD should also include clinical (wor-
sening headache, depressed level of consciousness, cranial
nerve deficits, ICP elevation) and radiographic findings
(worsening hydrocephalus) that confirm clamping trial
intolerance.
Although clamping trials are performed periodi-
cally, they are not standardized, and initiation and
frequency of such trials vary in different institutions. It is
imperative that any clamping trial data be sought for and
documented in the preoperative evaluation to ensure that
clamping can be safely done during patient transport to
and from the OR, and in the OR.
Importance of ICP and Multimodality
Monitoring Data
Often, ICP monitoring and CSF drainage is part of
a multimodal monitoring plan, which includes brain tis-
sue oxygenation, brain temperature, and continuous
electroencephalography.
The analysis of the continuous ICP waveform can
give indications of cerebral dysfunction.130 Normal ICP
waveform has 3 components: P1 (percussion wave), P2
(tidal wave), and P3 (dicrotic wave). The P1 wave is the
tallest and the sharpest wave, and results from arterial
pressure being transmitted from the choroid plexus. The
P2 wave follows P1, and is usually 80% as tall as the P1
wave, and correlates to brain compliance. The P3 wave is
caused by closure of the aortic valve (Fig. 1A).
Certain patients may have an abnormally high P2
waveform (Fig. 1B) demonstrating poor compliance. In
this case, the compensatory mechanism defined by the
compliance curve in the Monro-Kellie doctrine may be
exhausted at a lower ICP than expected. Certain patients
may have an abnormally high P2 waveform demonstrat-
ing poor compliance requiring therapy. In this case, the
compensatory mechanism defined by the compliance
curve in the Monro-Kellie doctrine may be exhausted at a
lower ICP than expected. In the noncompliant brain, this
reflection is stronger than the initial energy pulse P1,
whereas a normally compliant brain will absorb the en-
ergy generating a less intense P2 response. Dampened
waveform can be observed in patients with cerebral vas-
ospasm, postcraniectomy, and other skull-fusion defects.
The preoperative evaluation of all patients with an
indwelling EVD/LD should include recent ICP values,
trends, indices, and relationship with CPP and other
multimodality values made available.
Summary
To safely conduct an anesthetic on a patient with
CNS injury or risk thereof, a thorough preoperative
evaluation should include all important details of the
EVD and LD management. Communication with the
intensive care/ward staff and a thorough investigation of
FIGURE 1. A, Normal ICP waveforms. P1 percussion wave,
reflections off choroid plexus. P2 tidal wave, indicates brain
compliance. P3 dicrotic wave, correlates to closure of aortic
valve. P1 wave is the tallest, sharpest wave. P2 wave is no
greater than 80% of the P1 wave. B, Abnormal ICP waveforms.
Note here that P2 wave is higher than P1, which may indicate
reduced cerebral compliance. ICP indicates intracranial pres-
sure.
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the ICP and other multimodal monitoring data and EVD/
LD drain settings is paramount.
Preoperative Assessment of Patients with EVDs and
LDs (Class of Recommendation and Level of Evidence):
(1) A thorough preoperative evaluation should be per-
formed in all patients with an indwelling EVD and
LD that includes a focused history and physical exam
(Class I Recommendation; Level of Evidence E).
(2) Recommended preoperative evaluation of all patients
with an indwelling EVD and LD should include all of
the following (Class I Recommendation; Level of
Evidence E).
(a) CSF color and consistency.
(b) ICP values, ICP trends, autoregulation indices, and
relationship with CPP and other multimodal
monitoring data.
(c) Clinical (worsening headache, depressed level of
consciousness, cranial nerve deficits, ICP elevation)
and radiographic evidence of clamp trial intoler-
ance (worsening hydrocephalus).
(3) Incorporate all information pertinent to the EVD and
LD into a standardized preoperative handoff between
ICU/ward providers and anesthesia providers (Class I
Recommendation; Level of Evidence E.)
SECTION 3: TRANSPORTING PATIENTS WITH
EVDs
Introduction
Neurocritically ill patients with indwelling EVDs
frequently require transport from the ICU to other sites
for diagnostic and/or therapeutic procedures. These pa-
tients may be at risk of intracranial complications such as
high ICP during intrahospital transport (IHT) because of
direct patient movement and stimulation and/or
discontinuation of ICP treatment. However, change in
patient position can also lead to CSF overdrainage and
result in complications such as rebleeding of intracranial
aneurysm,131–133 subdural hemorrhage from disruption of
bridging veins,80–82 and reverse brain herniation.92
Anesthesiology providers are often involved in the
transport of these patients to and from the ICU and to
angiography and/or to and from the OR. There are no
guidelines regarding EVD management during IHT.
Background
The majority of guidelines for the transport of
critically ill patients, including those with ICP monitoring
lack recommendations specific to EVD manage-
ment.134–138 The American Association of Neuroscience
Nurses Guideline recommends routine clamping of EVD
before and during IHT to prevent CSF overdrainage but
does not address ICP monitoring or documentation
during IHT.129
The lack of recommendations regarding EVD
management is problematic because published studies
document several complications associated with IHT of
neurocritically ill patients, including unwanted alteration
in systemic blood pressure, respiration, and neurological
conditions.139–142 Andrews and colleagues prospectively
observed 50 IHTs of patients with traumatic brain injury
(TBI) who underwent computed tomography (CT) scan-
ning, magnetic resonance imaging, and transport to the
OR. Investigators reported high ICP as the most common
secondary insult (16%) during IHT.143 Picetti et al144
conducted a prospective observational study of 160 neu-
rocritically ill patients undergoing 288 CT transports;
32% of these IHTs were associated with EVDs. Although
ICP was monitored in only 32 of the 127 patients with
pretransport ICP monitoring, the incidence of ICP>20
mm Hg was high (66%). However, neither of these 2
studies distinguished between ICP monitoring types.
Moreover, in a case series of 7 patients with indwelling
EVDs who were transported for CT, there was a 27%
increase in average ICP from the initial value, and the
highest ICP noted during CT exam was 35mm Hg.
Kleffmann et al145 recently published a prospective ob-
servational study of 56 IHTs to CT of 43 patients with
ICP monitoring (50% were EVD). The authors reported
an 85% increase in average ICP from baseline during CT
scan and ICP therapy was required in 26% of IHTs.
Recently, Chaikittisilpa et al146 reported on the largest
series of 178 IHTs among 19 neurocritically ill cere-
brovascular patients whose EVD was clamped before
IHT. They reported that 12% of IHTs were associated
with post-IHT high ICP.21 ICP complications were only
observed among IHTs of patients who had an open EVD
setting in the ICU before transport. Pre-IHT ICP values
15 to 19mm Hg (odds ratio, 3.4 [1.08-10.76]), pre-IHT
ICP values Z20mm Hg (odds ratio, 12.94 [4.08-41.01]),
IHT for therapeutic procedure (odds ratio, 5.82 [1.76-
19.19]), and high hourly CSF output (odds ratio for every
mL/h, 1.11 [1.01-1.23]) are risk factors for ICP-related
complications during IHT.
Although these guideline focuses on perioperative
management, the transport recommendations should be
applicable to all IHTs. Personnel accompanying patient
during transport should be trained and competent in
management of intracranial hemodynamic perturbations
such as intracranial hypertension and cerebral hypo-
perfusion.
Summary
Best evidence from observational studies suggests
that neurocritically ill patients with indwelling EVDs are
at risk of intracranial hypertension during IHT. Routine
clamping of EVD for IHT may predispose the patients to
intracranial complications, particularly in patients with
open EVD status before IHT, those with pretransport
ICP >15mm Hg, and high hourly CSF output in the
ICU. Patients with LDs may experience similar compli-
cations but there are no data specific to IHT among pa-
tients with LDs.
Transporting Patients With Indwelling EVDs (Class
of Recommendation and Level of Evidence):
(1) While transporting patients with EVD and LD, it is
recommended to use a dedicated intravenous pole to
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mount the transducer and drainage system (Class I
Recommendation; Level of Evidence E).
(2) Do not routinely clamp EVD during IHT. The
decision whether to open or clamp EVD for IHT
should be individualized. Factors in pretransport
evaluation that may influence decision to travel with
EVD open or clamped to cerebrospinal drainage
(CSF) include: (1) hourly and daily CSF output and
setting of EVD, (2) EVD clamp status in the ICU, (3)
patient’s tolerance to clamping of EVD in ICU, and
(4) reason transport is undertaken (diagnostic vs.
therapeutic procedure). Test tolerance to EVD
clamping before making clamping decision as patients
at high risk for high ICP may benefit from opening of
EVD during IHT (Class I Recommendation; Level of
Evidence B-NR).
(3) If the EVD is clamped during transport, clamping
should be undertaken at 2 sites: (1) proximal port on
the EVD and (2) distal port on collecting system of
EVD (Class I Recommendation; Level of Evidence E).
(4) It is recommended to continue all pretransport ICU
monitoring, including intermittent clamping of EVD
for accurate ICP monitoring, and documentation of
ICP and other vital signs including end-tidal carbon
dioxide during IHT (Class I Recommendation; Level
of Evidence B-NR).
(5) Transport personnel should be prepared to treat
intracranial hypertension in patients with indwelling
EVDs during IHT (Class I Recommendation; Level of
Evidence E).
SECTION 4: INTRAOPERATIVE MANAGEMENT
OF EVD AND LD
Introduction
EVD and LD function as diagnostic and therapeutic
devices, and planning for a procedure requires knowledge
of the basic goals of management. Addition of a pressure
transducer allows monitoring and waveform display of
the ICP or ISP.
Setting Up an EVD or LD System in the OR
Some aspects of EVD or LD use can be idiosyn-
cratic for the specific device (Figs. 2A, B). Consistency
within an institution is important for choices such as the
reference level and measurement scale. The reference level
is most commonly the external auditory meatus for
EVDs. However, this convention is not followed rigor-
ously in clinical practice and published studies,94,147
which can lead to significant measurement errors if the
head of the bed is elevated above zero degrees.148 For
vascular surgery patients with LDs, common reference
levels include the right atrium (phlebostatic axis) or
lumbar catheter insertion site. The reference level is the
zero-pressure point for both an attached transducer and
the EVD/LD. The device is leveled by aligning the zero-
pressure point on the device with the reference level on
the patient; this is more accurate when a Carpenter
(bubble) or laser level is utilized.149,150
A flushless pressure transducer (Fig. 2B) is used
with EVD/LD that is connected to the patient through a
fluid column. This is the most common configuration with
the transducer located externally on the device and
measurement of the ICP or ISP by the fluid column in the
drainage catheter.151,152 In stark contrast to commonly
used transducer-based monitoring systems such as in-
vasive arterial blood pressure, central venous, or pulmo-
nary artery catheter, this flushless system is not
pressurized in any way. Under no circumstances should a
pressure transducer system with a pressure bag be as-
sembled or used in conjunction with EVD or LD.
Extra catheter systems are increasingly available
and separate the pressure transducer from the drainage
catheter by placing the transducer at the tip of the cath-
eter.153,154 ICP can also be measured separately from the
EVD at a variety of anatomic sites utilizing several
available technologies.11,151,152,155–157
The following steps can be followed when setting up
an EVD or LD intraoperatively (refer to educational
document that accompanies this article, Supplemental
Digital Content 2, http://links.lww.com/JNA/A47):
(1) Choose the appropriate reference level and measure-
ment scale (cm H2O). The reference level is most
commonly the external auditory meatus for EVDs or
the right atrium (phlebostatic axis) for vascular
surgery patients who have LDs.
(2) Mount the device upright158 by attaching to an
intravenous pole or to the patient’s bed. Make
appropriate changes to the drainage system when
the patient’s position changes relative to the drainage
system. It is good practice to clamp the EVD or LD
during changes in the position of the patient until it
can be releveled.156,159
(3) Level the device by aligning the zero point of the
device and the reference level on the patient using a
Carpenter (bubble) or laser level.149
(4) Monitor ICP by EVD or ISP by LD with an attached
transducer, if possible.
(5) Adjust the collection chamber to the specified height
based on the requirements of the procedure.
(6) The fluid path of the EVD/LD is a sterile system.
There should be a careful assessment of the risks/
benefits before opening any of these systems to reduce
the risk of infectious complications.
EVD/LD Management During Changes in
Position
The orientation of the patient can alter the
ICP,148,160–162 which must be accounted for in the man-
agement of EVD/LD. Intraoperatively there are frequent
changes in the position of the patient such as moving the
height of the table, altering the head elevation, and oth-
ers. In addition, there may be times when the position of
the device is moved relative to the patient such as from
one pole to another or if the height of the collection
chamber is altered. During such changes, it is good
practice to clamp the EVD/LD if clinically feasible
until the device and any attached transducer can be
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releveled.156,159,163 If changes in position are not accounted
for, then there is the risk of both overdrainage159,163 and
underdrainage of CSF as well as inaccurate pressure
measurements. Nevertheless, there are clinical situations
such as impending herniation where it is not feasible to
clamp the EVD/LD even briefly for position changes.
Positioning the patient for an intraoperative pro-
cedure is a unique phase of the case. The final patient
position during the intraoperative procedure may be quite
different from that in the ICU or the ward. In addition,
there are very significant and dynamic changes in CSF
pressure with postural changes164 as might occur as the
patient is moved between beds, turned prone, and others
to meet the requirements of the procedure. The EVD/LD
should be closed to drainage during positioning if clin-
ically feasible, and the management reassessed once in the
intraoperative position.
Inaccurate Pressure Measurements With
Simultaneous Drainage
Transducers that measure pressure by the fluid column
in the drainage catheter are always inaccurate if the EVD or
LD is simultaneously open for drainage.153,154,157,165 For
fluid-coupled systems, accurate pressure measurements re-
quire a static fluid column without simultaneous drainage
allowing the transducer to directly interface with the patient
line.157,165–167 This concern is relevant to transducers that are
mounted externally and transducers placed within the tip of
the drainage catheter.166 Although a value for ICP can be
trended while the device is simultaneously draining,168
the EVD/LD should be closed for accurate measurement at
least hourly.166,168 In some situations such as an anesthetized
patient with elevated ICP, it would be indicated to
obtain accurate pressure measurements more frequently than
hourly.
FIGURE 2. A, Components of an EVD (a representative example of antimicrobial-impregnated EVD). B, CSF collecting system.
CSF indicates cerebrospinal fluid; EVD, external ventricular drain.
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Dramatic measurement errors are possible with
transducers that measure with fluid coupling while at the
same time draining.165 Notable situations reported or
discussed in the literature are compressed or slit ven-
tricles, catheter blockage by debris, or catheter dislodge-
ment into the parenchyma.153,154,165,166 Accurately
measuring the pressure by stopping drainage and con-
necting the transducer directly to the patient line can
sometimes overcome this limitation.165,166
Continuous Drainage Versus Continuous
Monitoring
A common management decision is whether to
utilize continuous drainage with intermittent monitoring
(open EVD) versus continuous monitoring with inter-
mittent drainage (monitor EVD).169,170 Continuous
drainage impacts the ability of the EVD as a monitor to
detect trends.11 The decision to choose a specific man-
agement option is dependent on the indication for drain
placement and close consultation with the surgical team is
important. In adult severe TBI, continuous drainage
(open EVD) has been associated with better ICP con-
trol,19,170 but in patients with aneurysmal SAH, open
EVD management is associated with a higher rate of
complications.169,171,172
Documentation on Anesthesia Record for
Patients With EVD or LD
There are 5 items that should be documented in the
anesthesia record in patients with EVD or LD.
(1) Pressure= ICP/CPP or ISP/spinal cord perfusion
pressure (SCPP).
(2) Amount of CSF drainage (expressed in mL).
(3) Color of CSF and any change in color of CSF
observed during the procedure.
(4) Drain height relative to the reference level.
(5) EVD/LD status as set by the stopcocks in the device
(ie, open, clamped).
These items should be recorded at least hourly.
However, it is reasonable that frequency of ICP doc-
umentation follow clinical situations as changes in ven-
tilation, exposure to anesthetics, and hemodynamic
changes all cause frequent perturbations in ICP and CPP.
In such clinical scenarios, it may be desirable to document
ICP more frequently such as every 5 to 15 minutes. CSF
characteristics such as color, and any sudden change in
color including the presence of blood should also be
documented.129,156,173,174
With an electronic health record that automatically
imports patient data, care should be exercised to prevent
inaccuracies.171 This may occur due to technical issues
with the monitoring system or if automatic systems con-
tinue to import inaccurate data such as when the EVD
system is open for continuous drainage.
Summary
Intraoperative management of EVD and LD in-
cludes review of basic management goals, knowledge of
the device in use, and the ability to make accurate
measurements. This section includes recommendations
for preparing the EVD/LD, device management during
positioning, and best practice for documentation in the
anesthetic record. There is also a discussion of in-
accuracies that arise with traditional fluid-coupled sys-
tems if simultaneously open for drainage, and evidence
that is accumulating for various management strategies.
Intraoperative Management of Patients with EVDs
and LDs (Class of Recommendation and Level of Evi-
dence):
(1) Anesthesia providers should be knowledgeable
about the specific EVD and LD device in use locally
as details vary (Class I Recommendation; Level of
Evidence E).
(2) It is recommended to set up your anesthetizing
location following the standards of your institution,
including a consistent choice of reference level and
measurement scale (Class I Recommendation; Level
of Evidence E).
(3) It is recommended to level EVD or LD using a
Carpenter (bubble) or laser level rather than by
visual inspection (Class I Recommendation; Level of
Evidence B-NR).
(4) It is recommended to close the EVD/LD to drainage
during any changes in position if clinically feasible
(Class I Recommendation; Level of Evidence C).
(5) It is recommended to relevel the transducer after
changing patient position to ensure accurate mon-
itoring of ICP and adequate drainage of CSF (Class
I Recommendation; Level of Evidence C).
(6) It is recommended to monitor ICP or ISP with an
attached transducer that is appropriately leveled and
zeroed according to manufacturer guidelines (Class I
Recommendation; Level of Evidence E).
(7) A pressure bag and pressurized flush system should
not be attached to the EVD/LD (Class III; Level of
Evidence E).
(8) Pressure measurements should not be made while the
EVD or LD is simultaneously draining. Accurate
pressure measurements require a static fluid column
from the monitoring site to the externally mounted
transducers without simultaneous drainage (Class III
Recommendation; Level of Evidence B-NR).
(9) If open for continuous drainage, it is recommended
to close the EVD or LD to measure pressure at least
once per hour or more often if clinically indicated
(Class I Recommendation; Level of Evidence E).
(10) The decision for either continuous drainage or
continuous monitoring should be made in consulta-
tion with the surgical team. Continuous monitoring
with intermittent drainage may be considered in
patients with aneurysmal SAH, and continuous
drainage may be considered for adults with severe
TBI (Class IIb Recommendation; Level of Evidence
B-R).
(11) It is recommended to document the following
information pertinent to EVD and LD on the
anesthesia record at least hourly (Class I Recom-
mendation; Level of Evidence E): (1) pressure=
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ICP/CPP or ISP/SCPP, (2) amount of CSF drainage
(expressed in mL), (3) color of CSF and any change
in color of CSF observed during the procedure, (4)
drain height relative to the reference level, and (5)
EVD/LD status as set by the stopcocks in the device
(ie, open, clamped)
SECTION 5: MANAGEMENT OF EVD AND LD IN
SPECIAL CLINICAL SCENARIOS
Background
Despite careful maintenance and vigilance, compli-
cations may arise given the invasive nature of the devices.
EVD and LD need monitoring with the same attention
provided to other invasive monitoring devices. Safety can
be enhanced using dedicated protocols and bundles that
standardize the handling of EVD and LD.
Accidental Disconnection of EVD and LD
As an immune privileged organ, the brain is at high
risk for infections from bacterial contamination of
drainage devices. Standardized bundles for EVD place-
ment have significantly reduced rates of ventriculitis/
meningitis associated with EVD placement.123,175 Rele-
vant guidelines were recently published by the Society for
Neurocritical Care and emphasize the importance of
maintaining a closed, sterile drainage system.8 If drains
become inadvertently disconnected, the most immediate
threat to the patient is from uncontrolled leakage of CSF
as discussed below. A clamp should immediately be put
on the free end of the catheter to stop leakage. As the
system becomes contaminated by disconnection, all distal
parts should be replaced with new, sterile tubing.129 As
replacement of the proximal catheter carries new proce-
dural risk,129 it will not routinely be replaced after acci-
dental disconnection. There is no evidence to support
empiric antibiotic treatment after disconnection of an
EVD or LD system. After a new system is connected,
patency must be confirmed, especially in situations where
the catheter may have been displaced. In doubt, CT
imaging can confirm appropriate position of an EVD
catheter.
Drain Occlusion and Troubleshooting
No studies exist in the literature that compares
methods to troubleshoot EVD or LD. Published recom-
mendations represent expert opinion and practice sur-
veys.123,129,150 Sudden reduction in the hourly volume of
CSF drained can indicate an obstruction in the drainage
system. Similarly, if the ICP waveform is dampened, the
EVD may be occluded.176 Patency can be tested by briefly
lowering the drainage system. This may also be sufficient
to remove small amounts of material such as air bubbles,
blood clots, or tissue that may obstruct the tubing. If
patency is not restored by briefly lowering the system,
troubleshooting should continue by examining the
drainage tubing distal to the patient. If any occluding
material is present, the tubing can be flushed away from
the patient to remove the debris. Alternatively, the entire
drainage system can be changed, if necessary. Occlusion
of the proximal catheter can sometimes be resolved by
flushing the catheter toward the patient. This may in-
crease ICP, as the irrigation solution adds to the intra-
cranial volume. In patients with poor intracranial
compliance, irrigation with even small volumes can create
disproportionately large and dangerous increases of ICP,
possibly causing brain herniation. Proximal flushing
should only be attempted after discussion with the neu-
rosurgeon. Volumes of 0.5 to 2mL of sterile, preservative-
free isotonic sodium chloride solution can be used to flush
the EVD catheter, although a variety of antibiotic sol-
utions are sometimes used as well.177 Maintaining aseptic
conditions are essential. The technique should be guided
by institutional protocol and include, as a minimum,
sterile gloves, mask, and hair cover.175,178,179 The drain-
age system should be releveled and rezeroed after ma-
nipulation.
Overdrainage of CSF
Rapid drainage of large volumes of CSF from the
ventricles (ie, more than the 15 to 20mL produced in an
hour) can collapse the ventricles (especially when com-
munication to the extraventricular subarachnoid space is
compromised, as in noncommunicating hydrocephalus),
thus shrinking the cerebral hemispheres away from the
skull and dura. This creates tension on the bridging veins
and can cause acute subdural hematomas.180 In patients
with aneurysmal SAH and an unsecured aneurysm, rapid
drainage of CSF while the dura is closed can increase the
transmural pressure of the aneurysm and provoke re-
bleeding.181 Overdrainage from an EVD occurs most
commonly when the patient’s position is changed (eg, the
head of the bed or operating table is raised) without si-
multaneously adjusting the position of the EVD drainage
system.163 Drainage systems should be clamped whenever
patient position is changed. Patients with critically ele-
vated ICP may not tolerate even brief clamping of their
EVD during transport, in which case extra care needs to
be taken to secure the drainage system to the bed and to
monitor output. Once a new position is achieved, the
drain should be releveled and rezeroed.
Inadvertent overdrainage of significant amounts of
CSF is a more common problem with LDs, as they are
more prone to covert leakage of CSF around the drain or
through a persistent dural defect after removal. There are
many case reports describing complications from over-
drainage related to LDs.86,182–184 The most serious com-
plication is herniation,185–187 which is more likely to occur
when there is a differential in intracranial and spinal CSF
pressure.188 Acute herniation from lumbar overdrainage
of CSF can present with cranial nerve deficits, hyper-
tension, or bradycardia,189 and can lead to brainstem
hemorrhage.64 It can often be corrected by lowering the
head of the bed to Trendelenburg position.190 Injection of
sterile isotonic saline solution into the LD to replace lost
CSF has also been used as an emergency intervention.
Patients after decompressive hemicraniectomy are at in-
creased risk for paradoxical herniation from lumbar
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drainage of CSF. Their skull defect exposes the brain to
ambient pressure, so that relatively small decreases in
CSF pressure can cause significant brain sag and her-
niation (syndrome of the trephined).191,192 Tension
pneumocephalus and subdural hematoma from brain sag
have also been described as complications from LDs.93,193
CSF Drainage at Different Points During a Case
(eg, Before Craniotomy Bone Flap, Before Dural
Reflection, After Durotomy, or After Dural
Closure)
LDs are often placed electively for procedures that
carry a risk of postoperative CSF leak, such as skull base
surgery.194 They are used to drain CSF and improve ex-
posure during the procedure, and 10 to 20mL of CSF is
usually drained immediately before durotomy to “relax”
the brain, while the drain remains clamped for the rest of
the procedure. LDs are also used to reduce CSF pressure
and optimize SCPP during repair of thoracoabdominal
aortic aneurysms. CSF is usually drained to a pressure
goal, for example, 10mm Hg of CSF pressure (zeroed at
the right atrium). Use of CSF drainage for spinal cord
protection during thoracoabdominal aortic aneurysm re-
pair has recently been reviewed,195,196 and is not the focus
of the current document.
EVDs are not commonly placed for intraoperative
CSF drainage, but rather to treat ICP elevation caused by
noncommunicating hydrocephalus. Most patients will
come from the ICU with an EVD in place. CSF can be
drained from an EVD to reduce ICP and improve surgical
conditions, like a LD, with the difference that if the pa-
tient has noncommunicating hydrocephalus, CSF will be
removed only from the intraventricular space. Rapid re-
moval of a large volume of CSF will cause sudden de-
crease in ICP and can cause subdural hematoma, as
discussed above. In patients with aneurysmal SAH, sud-
den CSF drainage before durotomy in patients can result
in precipitous decrease in ICP and widening of transmural
pressure gradient and can cause fatal rerupture of cere-
bral aneurysm and should be avoided.197
Monitoring and Patient Safety
Changes in EVD output can provide important
clues into changes in patient condition. Increasing output
can indicate an increase in intracranial volume from
edema or hemorrhage, or rising ICP. Bright red output
from an EVD suggests an intraventricular hemorrhage or
SAH, such as from rerupture of an unsecured aneurysm.
This is a life-threatening emergency, and thus should be
communicated immediately to the surgical team. Alter-
natively, blood from a previous intraventricular hemor-
rhage may have been mobilized and transiently color the
CSF more brightly red. Although this is a much more
benign scenario, suspicion should remain high for a fresh
hemorrhage, especially if there are changes in vital signs,
such as hypertension or bradycardia, or if ICP increases.
Close communication is key to safe management.
Avoiding Accidental Injections Into EVD or LD
EVD tubing routinely has at least one 3-way stopcock
that allows access to the system. Commonly used EVD
systems use the Luer-lock standard and most EVD tubing
is not specifically marked to differentiate it from intra-
venous tubing. This creates the opportunity for providers to
inadvertently inject drugs into the ventricular system that
are meant for intravenous use. There are many case reports
and case series that describe accidental intrathecal injection
of agents as varied as anesthetic drugs,98,99 antibiotics,
chemotherapeutic agents, or gadolinium contrast, fre-
quently with devastating or fatal consequences.102–105 Care
should be taken to prevent this severe complication by
carefully labeling EVD tubing and access ports, and using
color-coded caps (please refer to educational document that
accompanies this publication, Supplemental Digital Con-
tent 2, http://links.lww.com/JNA/A47). In the future,
TABLE 5. Perioperative Checklist for Patients With External
Ventricular and Lumbar Drain
Preoperative assessment
& Obtain baseline neurological examination
& Review EVD (cm H2O) and LD setting (in mL/h of CSF drained)
& Review hourly CSF output to obtain baseline
& Review baseline ICP mm Hg, ICP trends, and available multimodal
monitoring data
& Review baseline CSF color and consistency
& Review clamp trials data if available
& Review coagulopathy profile
& Review antibiotic plan if anticipating new EVD/LD insertion in the
operating room
& Provide EVD and LD details during preoperative handoff between
intensive care/ward providers and the anesthesia providers
Transporting patients with EVD and LD
& Confirm decision to travel with EVD or LD clamp vs. open
& If traveling with EVD clamp, ensure clamping at both proximal port
on EVD and distal port on CSF collecting system
& Confirm HOB status during transport
& Confirm availability of dedicated intravenous pole for EVD/LD
mount
& Confirm leveling EVD at external auditory meatus and LD at
phlebostatic axis or at lumbar catheter insertion site
& Enable ICP monitoring during transport
& Confirm availability of medications needed to treat intracranial
hypertension during transport
Intraoperative management of indwelling drains
& Prepare transducer cable
& Identify EVD/LD tubing by appropriate unique labeling
& Confirm HOB status during surgical procedure
& Confirm leveling of EVD at external auditory meatus and LD at
phlebostatic axis
& Obtain ICP waveform and baseline ICP value
& Record q 1-h EVD/LD setting
& Record at least q 1-h ICP values (recorded with EVD closed to drain)
& Record at least q 1-h EVD/LD drain output (expressed in mL)
& Provide EVD and LD details during intraoperative handoffs between
anesthesia providers
Inform surgeon if any Z1 of the following
& Sudden decline in CSF drainage or no drainage from EVD or LD, or
occlusion of EVD or LD
& If drain output is >15-20mL at any time or in any given hour
& Sudden change in CSF color
& Dampening or loss of ICP waveform
cm H2O indicates centimeters of water; CSF, cerebrospinal fluid; EVD, ex-
ternal ventricular drain; HOB, head-of-bed; ICP, intracranial pressure; LD, lum-
bar drain.
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TABLE 6. EVD and LD Clinical Competency Checklist for Clinicians Involved in Perioperative Care
Name of Provider__________________ Date_________________
Validated by______________________
Steps
Date/Initials of
Validator
Has the anesthesia technician already tightened the connection between the bottom of the burette and the bag (loose from the manufacturer,
similar to pressure tubing for arterial lines) and primed the system using sterile technique (wearing face mask, making sure not to touch sterile
connections with bare hands or only clean gloves). Only a flushless transducer system is used for EVD and LD
Leveling and zeroing EVD system
& Level flushless transducer and red “0” on drainage system at EAM. State why EAM level is typically chosen for neurosurgical CSF drainage
systems (Answer: approximate level of Foramen of Monro, drainage channel between lateral ventricles)
& Raise burette to desired level (EAM or EAM± _____ cm H2O). State rationale (Answer: ICP must rise above pressure-level indicator of
drip chamber to drain CSF)
& Turn stopcocks on patient line off until ready to connect and drain
& Use sterile technique to connect ventricular catheter with CSF drainage system (face mask and sterile gloves)
& Once system is attached to ventricular catheter, attach pressure cable to flushless transducer. Open panel mount (reference) stopcock port to
the right of the flushless transducer (remove injection cap); turn stopcock off to the patient and open the system to air. Press, “zero” on
bedside monitor. When monitor says “0,” return stopcock, upright, and replace injection cap
Monitoring ICP and draining CSF
& Demonstrate correct position of stopcock to monitor true ICP (not trend) (Answer: stopcock should be at 12 o’clock)
State requirements for true ICP determination (Answer: corresponding waveform and numeric display; ICP is a mean value in mm Hg)
& Demonstrate correct position of stopcock to trend ICP (not true ICP) and drain (Answer: 3 o’clock)
& Demonstrate correct position of stopcock to prevent drainage and not transduce ICP (Answer: 6 o’clock and may also turn stopcock toward
patient on patient line closest to ventricular catheter)
& Demonstrate correct position of stopcock to transport and monitor true ICP at the same time (Answer: 12 o’clock)
Complications of EVD
& State common complications of EVD
J (Answer: underdrainage; overdrainage, infection, possibly rebleeding. Overdrainage may result in subdural hematoma or herniation)
& State the usual recommended CSF drainage rate (Answer: 20mL/h; adults make 500mL/24 h which is 22mL/h; so drain the amount that is
made in an hour)
& State normal ICP (Answer: <20mm Hg)
& State calculation of CPP (Answer: MAP-ICP=CPP. 60mm Hg is generally considered acceptable)
& State that CSF drainage may be desired continuously or intermittently. Defer to neurosurgery; however, do not drain, in general over 20mL/
h
& Record ICP/CPP and CSF output at least hourly in electronic record
&Why would it be bad practice to attach the transducer to a pressure bag set-up? If so, the answer of course would be, you will deliver 3mL/h
of fluid to an already tight space and if someone activates the fast flush, you could have sustained ICPs with herniation (EVD) or if a LD for
aortic aneurysm repair, possibly create/increase spinal cord ischemia with paraplegia
Transport
& Demonstrate position of CSF drainage system during transport and position of stopcock (Answer: CSF drainage system upright on IV pole,
leveled; flushless transducer zeroed with transport monitor and stopcock at 12 o’clock to allow accurate monitoring of ICP in transport but
no drainage during transport). Only leave CSF drainage system open to transport if herniation is pending. If left open during transport must
observe CSF drainage constantly and avoid overdrainage
Has the anesthesia technician already tightened the connection between the bottom of the burette and the bag (loose from the manufacturer,
similar to pressure tubing for arterial lines) and primed the system using sterile technique (wearing face mask, making sure not to touch sterile
connections with bare hands or only clean gloves). Only a flushless transducer system is used for EVD and LD
Leveling external LD system
& Level the red “0” on drainage system at phlebostatic axis
& Raise burette to desired level (EAM or EAM± _____ cm H2O). State rationale (Answer: ICP must rise above reference level of drip
chamber to drain CSF)
Turn stopcocks on patient line off until ready to connect and drain
Use sterile technique to connect lumbar catheter with CSF drainage system
Draining CSF
& Demonstrate correct position of stopcock to drain CSF
J (Answer: 3 o’clock or 9 o’clock)
& Demonstrate correct position of stopcock to prevent drainage
J (Answer: 6 o’clock and may also turn stopcock toward head at port on patient line closest to lumbar catheter)
Complications of LD
& State common complications of LD
& (Answer: underdrainage; overdrainage, infection, possibly rebleeding. Overdrainage may result in subdural hematoma or herniation)
& State the usual recommended CSF drainage rate
J (Answer: 10-15mL/h; for a LD; the risk of herniation may be greater than with a LD related to downward pull of CSF drainage at the
lumbar level)
J Record CSF output at least hourly in electronic record
Why would it be bad practice to attach the transducer to a pressure bag set-up? If so, the answer of course would be, you will deliver 3mL/h of
fluid to an already tight space and if someone activates the fast flush, you could have sustained ICPs with herniation (EVD) or if a LD for
aortic aneurysm repair, possibly create/increase spinal cord ischemia with paraplegia
Transport
& Demonstrate position of CSF drainage system during transport and position leveled at EAM and turned off to drainage, stopcock at 12 or 6
o’clock
CPP indicates cerebral perfusion pressure; EAM, external auditory meatus; EVD, external ventricular drainage; ICP, intracranial pressure; LD, lumbar drain.
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manufacturers should design access ports that cannot be
confused with intravenous access ports, similar to the safety
pin system used for anesthetic gases.102 Treatment of acci-
dental intrathecal injection is supportive. Aspiration of
CSF and replacement with isotonic sodium chloride to
“lavage” the intrathecal space has been suggested as an
emergent intervention to reduce neurotoxicity, especially
when caustic agents such as chemotherapeutic drugs have
been injected inadvertently.100,101 No controlled studies
exist, however, and success of this intervention is mixed in
reported cases.
Intrathecal Injection of Fluorescein Dye for CSF
Leak
Intrathecal injection of fluorescein dye through the
LD is sometimes indicated intraoperatively during repair
of CSF leaks to identify the location of actual defect. In
addition, it is useful to assist in locating additional leak
sites and to confirm the watertight closure of the defect.
Although it has been used worldwide for this purpose, the
intrathecal fluorescein is an off-label use of the product;
hence, informed consent is required in many centers.
The usual dose range used is 10 to 50mg (0.1 to
0.5mL of 10% fluorescein with 9.5mL of CSF) injected
over 30 minutes.198 Complications are mostly related to
meningeal irritation that include headache, nausea and
vomiting, dizziness, nuchal pain, limb weakness, gener-
alized seizures,199 and cranial nerve palsy. Most compli-
cations are dose related and transient, and typically
resolve within 7 to 10 days. Limited evidence suggests that
fluorescein injection should be avoided in patients with
history of seizures, hydrocephalus, spinal stenosis, and
cerebral edema. We strongly recommend that individual
institutions should develop their own protocols for in-
trathecal administration of fluorescein.
Summary of Management of EVDs and LDs in
Special Clinical Scenarios
Because of invasive nature of these devices, com-
plications that occur perioperatively include accidental
disconnection, drain occlusion, overdrainage, and in-
advertent administration of drugs into the drains. Extra
vigilance, clear labeling of the drains, and the develop-
ment of standardized protocol on the handling of EVD/
LDs are some of the measures that can minimize these
complications.
Management of EVD and LD in Special Clinical Sce-
narios (Class of Recommendation and Level of Evidence):
(1) EVD or LD tubing that is accidently disconnected
should be clamped immediately to prevent over-
drainage of CSF (Class I Recommendation; Level of
Evidence C).
(2) If the EVD or LD systems are contaminated by
disconnection, all distal parts should be replaced with
new sterile tubing (Class IIa Recommendation; Level
of Evidence E).
(3) Routine flushing of the EVD or LD catheter should
not be performed (Class III Recommendation; Level
of Evidence E).
(4) In patients with ruptured cerebral aneurysm, sudden
excessive drainage of CSF before securing the
aneurysm can provoke aneurysm rerupture and
should be avoided (Class III Recommendation; Level
of Evidence C).
(5) Identification of EVD or LD tubing by appropriate
labels and use of other visual aids is recommended to
prevent confusion with intravenous ports (Class I
Recommendation; Level of Evidence E).
(6) Accidental intrathecal injection should be recognized
and reported to the neurosurgeon (Class IIa Recom-
mendation; Level of Evidence E).
(7) Lavage of the intrathecal space after accidental
injection is not recommended (Class III Recommen-
dation; Level of Evidence C).
(8) Establish institutional standards to ensure safe intra-
thecal injection of fluorescein dye through LD in
patients with suspected CSF leak (Class I Recom-
mendation; Level of Evidence E).
SECTION 6: PERIOPERATIVE CHECKLIST,
DEVELOPING CLINICAL COMPETENCIES FOR
EVD/LD, AND CONTINUED MEDICAL
EDUCATION
Use of a Perioperative EVD and LD Checklist
The material presented above provides a framework
from which a perioperative checklist can be constructed.
Such a checklist (Table 5) incorporated into a shared mental
model200–202 is intended to reduce systematic errors during
perioperative management of patients with EVD or LD.
This perioperative checklist can be used for all patients
undergoing perioperative care, and may be included in
preoperative handoffs between ICU/ward providers and
anesthesia providers, and during intraoperative handoffs
between various anesthesia providers. Checklist can be
modified and used during IHT of neurocritically ill patients.
Clinical Competence and Continued Medical
Education Related to Management of Patients
With EVD/LD
For clinicians involved in perioperative care of pa-
tients, one of the core competencies is the ability to ad-
minister safe and reliable care on a consistent basis. In
relationship to patients with EVD and LD, this translates
to acquiring knowledge about the basics of EVD and LD
relevant to the perioperative period, at the same time,
possessing essentially the same skills as neuroscience
nursing while managing these drains within the confines
of perioperative care.
Although management of patients with EVD and
LD may be expected from all clinicians involved in peri-
operative care of patients, there is lack of published per-
ioperative guidelines and standards.203–205 However, there
are various educational materials that are available on the
World Wide Web that provide institutional guidance to
practitioners regarding EVD and ICP monitor-
ing.159,173,174,205–207 A comprehensive clinical competency
checklist can be found in Table 6.
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This or a modification of this checklist may be used
by institutions to establish competency standards for
clinicians involved in perioperative care of patients with
EVD and LD. It is recommended that institutions es-
tablish an annual evaluation of competency, a continued
medical education program, and a refresher course208 for
all clinicians involved in perioperative care of patients
with EVD and LD.
Summary
A clinical competency checklist comprising setting
up and maintenance of EVD or LD, along with a com-
prehensive checklist covering preoperative assessment,
transporting patients, intraoperative management, and
evaluation of patient under special circumstances pro-
vides a framework to clinicians involved in perioperative
care of patients with EVD or LD.
Perioperative Checklist, Clinical Competency, and
Continued Medical Education (Class of Recom-
mendation and Level of Evidence):
(1) It is recommended that clinicians involved in peri-
operative care of patients must familiarize themselves
with information regarding indications, contraindica-
tions, leveling, zeroing of transducer, and current
standards related to transporting and intraoperative
care of patients with EVD or LD (Class I Recom-
mendation; Level of Evidence E).
(2) It is reasonable to provide educational material aimed
at perioperative management of EVD and LD in form
of text and/or multimedia to all clinicians involved in
perioperative care of patients (Class IIa Recommen-
dation; Level of Evidence E).
(3) To standardize care of patients with EVD and LD,
and to promote a shared mental model, use of a
perioperative checklist is recommended (Class I
Recommendation; Level of Evidence E).
(4) It is recommended that institutions set up competency
standards for clinicians involved in perioperative care
of patients with EVD and LD (Class I Recommen-
dation; Level of Evidence E).
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